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Relationships between health and economic prosperity or economic growth are difficult to assess. 
The direction of the causality is often questioned and the subject of a vigorous debate. For some 
authors,  diseases  or  poor  health  had  contributed  to  poor  growth  performances  especially  in  low-
income countries. For other authors, the effect of health on growth is relatively small, even if one 
considers that investments which could improve health should be done. It is argued in this paper that 
commonly used health indicators in macroeconomic studies (e. g. life expectancy, infant mortality or 
prevalence rates for specific diseases such as malaria or HIV/AIDS) imperfectly represent the global 
health status of population. Health is rather a complex notion and includes several dimensions which 
concern fatal (deaths) and non-fatal issues (prevalence and severity of cases) of illness. The reported 
effects of health on economic growth vary accordingly with health indicators and countries included in 
the analyses. The purpose of the paper is to assess the effect of a global health indicator on growth, the 
so-called disability-adjusted life year (DALY) that was proposed by the World Bank and the WHO in 
1993. Growth convergence equations are run on 159 countries over the 1999-2004’s period, where the 
potential  endogeneity  of  the  health  indicator  is  dealt  for.  The  negative  effect  of  poor  health  on 
economic growth is not rejected thus reinforcing the importance of achieving MDGs. 
 
Keywords: Disease Global Burden, DALYs, economic growth, macroeconomic health 
impact, cross-country analysis  










































1.  Introduction 
Sen’s works on human capabilities and the emergence of AIDS have renewed the interest 
given  to  the  link  between  health,  welfare,  and  prosperity.  In  2001,  the  Commission  on 
Macroeconomics and Health (2001) concluded that diseases raise barriers to economic growth 
and that countries have to invest in health. Theoretical arguments can also be found in growth 
theory where capital accumulation is meant to drive growth. Human capital investments are 
known for a long time as basic candidates explaining growth performances (e. g. Schultz, 
1961; Mankiw et al. 1992). Recent studies stress either the role of education on income per 
capita growth in Asian emerging countries (Chi, 2008; Kwack and Lee, 2006; Kang, 2006) or 
the effect of health status on growth through its effect on education (Li and Huang, 2009).  
At a microeconomic level
2, several studies found that poor health has negative effects on 
economic prosperity and living conditions. A great variety of health indicators are used and 
concern either one specific communicable disease such as Guinea worm, schistosomiasis or 
malaria  (Weisbrod  and  Helminiak,  1977;  Audibert,  1986;  Audibert,  1997a  and  1997b; 
Audibert  and  Etard,  1998;  Girardin  et  al.,  2004),  or  self-assessed  health  status  relied  to 
activities of daily living and to general health (Schultz and Tansel, 1997; Gertler and Gruber, 
2002; Christiaensen, Hoffmann and Sarris, 2007; Liu et al., 2008).  
At a macroeconomic level, several authors consider that communicable diseases, among 
others,  had  contributed  to  slow  down  economic  development  of  low  income  countries. 
Nevertheless, their affirmation on this negative macroeconomic effect is still hotly debated as 
some  methodological  issues  are  not  satisfactorily  addressed  (see  the  comprehensive  and 
critical review of Packard, 2009). Moreover, several studies argue that the negative effect of 
health on growth is not so obvious. Acemoglu and Johnson (2006), using international data 
from the epidemiological transition period, find that an increase in life expectancy generated 
by  a  decrease  in  mortality  rates  had  a  small  positive  effect  which  grows  over  the  post 
epidemiological transition. The latter was not enough important to compensate for increases 
in population. Consequently, life expectancy increases do not lead to a significant increase in 
per capita economic growth. This study makes reminiscent previous results of Barlow (1968) 
with regard to malaria eradication and of Over (1992) with regard to economic effects of 
                                                 
2  The  literature  on  links  between  health  and  economic  well-being  or  prosperity  at  microeconomic  level  is 
abundant. Strauss and Thomas (2007) recently did an exhaustive literature review of this topic at microeconomic 









































AIDS as well. Indeed, Bell, Bruhns and Gersbach (2006), using an overlapping generations 
model simulate relaxed effects of AIDS on economic growth in Kenya by 2050.  
There are at least three reasons that could explain difficulties to accurately assess health 
impacts at the macroeconomic level. First, links between health and development or growth 
are complex and health effects could also be channelled by education, the environment, and 
cultural behaviours as well. When, due to missing adequate indicators, these behaviours are 
not included in the model, the estimated health effects will be biased or hidden by unobserved 
heterogeneity  (Thomas,  2009;  Strauss  and  Thomas,  2007).  Second,  health  is  subject  to 
random  measurement  errors  either  due  to  poor  measurement  facilities  (lack  of  good 
equipment  for  setting  appropriate  diagnosis,  low  human  resource  training,  lack  of  good 
registration), measurement variability over the day (e.g. blood pressure) or the year (e. g. 
malaria  indicators).  Third,  health  status  is  a  rather  complex  notion  that  includes  several 
dimensions.  
Despite these difficulties of measuring multiple dimensions of health and therefore global 
health status, macroeconomic effects of health have been more often studied using health 
indicators such as life expectancy at birth, infant mortality rates, or anthropometric measures. 
Studies results can be questioned. For instance, life expectancy at birth is closely related to 
infant mortality or high adult mortality rates, due to AIDS and alcoholism, which is a specific 
and partial aspect of health status. Anthropometric measures focus mainly on nutritional status 
of children which is not representative of overall health status. Our purpose in this article is to 
study the relationship between health and development at the macroeconomic level, by using 
the global health status indicator provided by the World Health Organisation and the World 
Bank, namely the Disability Adjusted Life Years (DALY). 
The rest of the paper is organized as follows. Section 2 is devoted to health measurement 
issues. Different measures of health indicators used in the growth literature are discussed 
before presenting exploring the more global one which is focused on in this study. Section 3 
reviews  the  theoretical  and  empirical  literature  on  the  link  between  health  outcomes  and 
economic performances. The empirical setting and the results are presented in section 4 and 5. 









































2.  Looking for a global health indicator 
Health measurement is a hard task since, contrary to economic indicators, health is multi-
dimensional
3, and measured with errors. Moreover, researchers, either in a perspective of 
public health, health research, or economic health research, have developed a battery of health 
indicators, among which few however are satisfactorily measured (Murray and Frenk, 2008; 
Murray,  2007)
4.  If  it  is  crucial  to  understand  what  each  indicator  measures  (Strauss  and 
Thomas, 2008), it is also important to assure that the health indicator used fits the purpose of 
the study. 
The  most-used  indicators  of  health  conditions  at  the  macroeconomic  level  are  life 
expectancy at birth and infant mortality rates (Strauss and Thomas, 2008). Those indicators 
are  considered  reflecting  the  general  health  conditions  and  supposed  to  be  positively 
associated with economic growth. It is true that life expectancy is higher and infant mortality 
lower  in  richer  countries  than  in  poorer  countries.  Indeed,  the  correlation  between  life 
expectancy  at  birth  and  GDP  per  capita  is  not  systematic  as  life  expectancy  is  in  some 
countries lower (or higher) than expected given GDP per capita (Southern Africa, Gabon or 
Indonesia, for examples,  Strauss and Thomas, 2008). Over time, per capita incomes have 
diverged while life expectancy and infant mortality have converged (Deaton, 2006; Jack and 
Lewis,  2009).  Life  expectancy  and  infant  mortality  are  inadequate  indicators  of  the 
population’s health in high income countries and for some upper middle income countries as 
life  expectancy  is  high  and  infant  mortality  very  low  or  low.  For  low  and  lower  middle 
income countries, those indicators are more adequate due to their poor levels. For that reason, 
studying  the  relationships  between  health  and  economic  development  or  growth  in  cross-
country studies using infant mortality or life expectancy at birth is not really appropriate.  
The emergence of HIV/AIDS and the highly prevalence (more than 15%) in some southern 
African  countries  (Botswana,  Lesotho,  Namibia,  South  Africa,  Swaziland,  Zambia,  and 
Zimbabwe, UNAIDS
5), has motivated several studies focusing on their economic effects. But, 
little evidence of a correlation between HIV/AIDS and GDP per capita was found (Strauss 
and Thomas, 2008). With the renewal interest for malaria, some authors (Sachs and Malaney, 
                                                 
3 Whatever the approach chosen (medical, self-assessment or functional) for measuring health, poor health is 
considering  as  a  deviation  between  the  observed  health  and  a  norm.  This  deviation  may  occur  into  either, 
physical, mental, or social well-being dimension.  
4 For a discussion on the issue and challenge of health measurement, see Mwabu, 2007; Strauss and Thomas, 










































2002; McCarthy, Wolf and Wu) focused on the effect of that disease on African countries 
growth. 
As underlined by Jack and  Lewis (2009), the  effect of  a population’s  health status on 
national income varies accordingly with the health indicator used. Most health indicators used 
in the literature capture one dimension of the population health. They either relate to fatal 
issues, underlying the rule of rescue (life expectancy
6, mortality indicators), or to non-fatal 
ones (morbidity indicators) issue of illness (Audibert, 2009). Those indicators neither take 
into account other dimensions of health, such as invalidity, handicap or social consequences, 
nor multidimensional characteristics of health.  
3.  Relationship between health and growth 
The  implicit  question  of  the  connections  between  health  and  growth  is  twofold:  Do 
investments in health boost economic growth; do economic opportunities help to improve 
health? Directions of the causality between health and economic growth are still the subject of 
discussions as well as its bidirectional causality (Jack and Lewis, 2009; Duncan, 2009; Weil, 
2010).  Nevertheless,  estimating  those  relations  is  difficult,  specifically  in  cross-country 
analyses.  Several  authors  like  Schultz  (2008),  argue  that  there  is  a  need  “for  a  more 
conceptual hypotheses refinement and empirical testing and comprehensive study of specific 
pathways  which  could  improve  our  knowledge  about  those  causal  connections”.  Those 
pathways may concern life styles, the environment (social, economic and physical) and health 
services (Aguayo-Rico et al. 2005).  
3.1.  Theoretical background 
This paper builds on the idea of health being a capital: people are endowed an initial stock 
which  can  depreciate  through  time  with  age  but  which  is  the  subject  of  investments 
(Grossman, 1972; see Mwabu, 2007 for a literature review on the concept of health capital). 
From such a perspective, Van Zon and Muysken (2005) mention two positive effects of health 
on economic growth. First, the health status of population increases the efficiency of labour; 
second, human capital accumulation requires “health hours”. These effects add to those of 
Bloom and Canning (2000) who argue that improvements in longevity increase savings and in 
turn investments; moreover there exists a demographic dividend generated by a decline in 
                                                 
6 In low income countries, life expectancy is mainly determined by infant mortality, and also in countries where 









































child  mortality.  The  effect  of  health  on  economic  growth  has  also  been  the  subject  of 
theoretical investigations. One may refer to the augmented Solow model developed and tested 
by Mankiw et al. (1992). Other authors have included health in optimal Cass-Koopmans like 
growth models and thereby justified its inclusion in conditional convergence analyses as well: 
the  productivity  in  the  health  sector  has  a  positive  impact  on  all  steady  state  variables 
(Muysken  et  al.  2003).  At  last,  health  investments  are  taken  into  account  in  endogenous 
growth models à la Lucas (1988) with two characteristics: health is produced with decreasing 
returns  whereas  human  capital  is  built  with  increasing  returns.  Health  can  either  be  a 
complement or a substitute to growth when the effect of health on longevity is internalised 
(van  Zon  &  Muysken,  2001).  Neo-schumpeterian  growth  models  also  allow  identifying 
several channels through which population health impacts their long run growth performance. 
One of these channels puts forward the ability of health improvements to stabilise the gap in 
living standards relatively to technology leaders (Howitt, 2005). 
3.2.  Empirical estimation of the links between health and 
economic growth or prosperity 
The association between income level and population health has been extensively studied 
in the literature for several years. At the macro-level, the apparent link between those two 
variables has been highlighted by the Preston’s  curb (1975) which  establishes an upward 
shifting relationship between life expectancy and national income per capita between 1900 
and  1960.  This  correlation  however  neither  gives  pieces  information  on  the  sense  of  the 
causality nor on the different channels through which health may impact economic growth.    
These channels may be identified. The first is that healthier people are more productive 
and more efficiently supply labour. Indeed, they can work harder and longer, and think more 
clearly. Health status may also improve economic outcomes through its effect on education. 
Improvements in health raise the motivation to attend high level schooling, since the returns 
to investments in schooling are valuable over a longer working life. Healthier students also 
have more attendance and higher cognitive functioning, and thus receive a better education 
for a given level of schooling. Furthermore lower mortality rates and higher life expectancy 
encourage savings for retirement, and thus raise investment levels and capital per worker. 
Table A8 in Appendix A gives a synthesis of some of the main studies that explored the 









































Some scholars assess empirically how health indicators may influence economic returns in 
a specific region using individual or household data while others measure the same effect at 
more  aggregated  level,  between  countries  or  regions.  All  these  studies  could  be  divided 
according to the health indicators considered. Indeed, a number of studies utilize health inputs 
whereas others used health outcomes. Health inputs are the physical factors that influence an 
individual’s  health  and  comprise  nutrition  variables,  exposure  to  pathogens,  and  the 
availability of medical care (Weil, 2007). Health outcomes are related to the health status of 
an individual or a given population. These include health indicators broadly considered such 
as life expectancy, mortality indicators, the ability to work hard, and cognitive functioning as 
well as specific illness prevalence such as malaria, AIDS/HIV, Guinea worm, etc.   
Researchers generally conclude that population health remains an important predictor of 
economic  outcomes.  Life  expectancy  at  birth  positively  impact  economic  performances 
(Barro  &  Lee, 1994; Cuddington & Hancock,  1994; Barro  & Sala-I-Martin, 1995; Barro, 
1996; Sach & Warner, 1997; Bloom & Malaney, 1998; Bloom, Canning & Malaney, 2000; 
Arora, 2001; Bloom, Canning & Sevilla, 2005; Acemoglu & Johnson, 2007, 2009; Bloom, 
Canning & Fink, 2009). Bloom et al. (2004) show that life expectancy has a positive, sizable, 
and statistically significant effect on aggregate output even when experience of the workforce 
is controlled for. Sala-i-Martin et al. 2004 departing from the numerous potential explanatory 
variables in cross-country growth regressions, implement a model selection criterion. The set 
of explanatory variables which emerges from the analysis includes human capital variables 
and more especially life expectancy at birth. Acemoglu and Johnson’s results (2007) are less 
conclusive with results indicating that increases in life expectancy have no significant effect 
on output per capita. But their results are still questioned on the choice of an adequate health 
indicator, the limited content of their sample, and the quality of their instrumental variable 
(Acemoglu & Johnson, 2009). 
Mortality or survival variables are also used in the literature as overall health outcome 
indicators  that  impact  economic  growth  (Hamoudi  &  Sachs,  1999;  Bhargava  et  al.  2001; 
Bloom & Canning, 2005; Weil, 2007; Lorentzen et al. 2008). Using cross-national and sub-
national data, Lorentzen et al. (2008) argue that high adult mortality rates reduce economic 
growth by shortening time horizons since they favour riskier behaviours, higher fertility rates, 
and lower investments in physical capital. Other authors are also interested in the impact of 
specific diseases on economic returns. In fact, many diseases like HIV/AIDS and malaria are 









































1999;  Bonnel,  2000;  Gallup  &  Sachs,  2001;  Sachs,  2003;  Bell,  Devarajan  and  Gerbasch 
(2003);  McDonald  &  Roberts,  2006;  Audibert  et  al.,  1998,  1999,  2003,  2006,  2009). 
McDonald  &  Roberts  (2006)  have  calculated  that  the  elasticity  of  economic  growth  to 
HIV/AIDS prevalence in Africa is -0.59. Carstensen & Gundlach (2006) found that malaria 
prevalence causes quantitatively important negative effects on income even after controlling 
for  institutional  quality.  Wiping  out  malaria  from  sub-Saharan  Africa  could  increase  that 
continent’s per capita growth rate by as much as 2.6% a year (Gallup and Sachs, 2001). 
A second strand of the literature assesses the importance of health inputs on development. 
Calories intakes and economic output are positively correlated since richer countries have 
more health inputs than poorer countries: hourly earnings, farm outputs and wages rise with 
increased  per  capita  calorie  and  protein  intakes.  Using  household-level  data  from  Sierra 
Leone, Strauss (1986) demonstrate that caloric intakes have a highly significant effect on 
labour productivity while Sahn & Alderman (1988) show that calories impact wages. It is 
well-known that malnutrition is detrimental to physical and mental development while both 
have an effect on education, and then on future incomes. Using data on monozygotic twins in 
the USA, Behrman & Rosenzweig (2004) estimate the effect of intrauterine nutrient intake on 
adult health and earnings and thereby evaluate the effectiveness of programs focused on birth 
weights increase. They found that differences in birth weights between identical twins can be 
used to identify the life cycle consequences for physical attributes, schooling, and earnings 
from increasing foetal nutrient intake. 
Another nutrition measurement largely used in the empirical literature is anthropometric 
indicators (Alderman and Behrman, 2006). Several studies show that low birth weights and a 
delay  in  childhood  development  (height)  have  an  impact  on  future  wages  or  labour 
productivity;  that  taller  people  tend  to  be  more  productive  (Deolalikar,  1988;  Sahn  and 
Alderman, 1998; Strauss and Thomas, 1998; Huffman and Orazem, Berham, 1999; Chapoto 
and Jayne, 2008). A study conducted in rural Zimbabwe shows that improved pre-schooler 
nutritional status, as measured by height for age, is associated with increased height as a 
young adult, a greater number of grades of completed schooling, and an earlier age at which 
the child starts school (Alderman & al. 2006). Indonesian women who are 0.5 cm taller due to 
early-life  rainfall  shocks  complete  0.32  more  year  of  schooling;  live  in  households  with 









































2005). Weil (2007) combines micro and macro data and demonstrates that population height 
is an important economic development predictor.
7  
Even  though  malnutrition  indicators  remain  the  most  health  input  used  in  economic 
literature,  others  indicators  are  utilized  such  as  treatment,  life  styles  and  health  services. 
Bleakley (2007) found that areas that had higher levels of malaria or hookworm infection 
prior  to  eradication  experienced  greater  increases  in  school  attendance  and  literacy  while 
Miguel  and  Kremer  (2005)  find  that  giving  de-worming  medicines  to  school  children 
improves school participation in Kenya. 
If  at  a  micro-level,  numerous  studies  found  that  poor  health  have  an  economic  effect 
through several channels, this effect is less evident at a macro-level. The next section tries to 
deal with that bias.  
4.  Empirical framework analysis 
The  analysis  of  the  effect  of  health  on  economic  growth  is  based  on  the  augmented 
neoclassical growth equation, which includes the global health status variable as a regressor 
combined with initial GDP per capita as catch up variable and other exogenous variables.  
i ik i i X Health y ε + δ + β + α =                (1) 
Where yi is the annual growth rate of GDP per capita with subscript i designating the 159 
potential countries included in our sample (see Appendix A7 for the list of the countries); 
Healthi is the global health indicator; Xik the matrix of the k control variables and εi is the 
independently  and  identically  distributed  error  terms;  α,  β  and  δ  are  parameters  to  be 
estimated.  Moreover  regional  dummy  variables  are  also  included  to  control  for  regional 
specific effects. 
Data and variables are presented first and then econometric specification.  
4.1.  Data and variables 
The data used in this paper are annual averages over the 1999-2004’s period, since our 
health data are not available apart from these years, and included about 160 WHO member 
states (see list Table A7). The main thesis of this paper is that macroeconomic effects of the 
                                                 
7 Body Mass Index (BMI measured by weight/height
2 and expressed in kg/m
2) can also be used. See Thomas & 









































global health status are accurately caught by the Disability-Adjusted Life Year (DALY) per 
capita calculated by the World Health Organization (WHO). This indicator is proposed by the 
World Bank and WHO since 1993 (the World Bank, 1993). Its represents “a one lost year of 
healthy life and extends the concept of potential years of life lost due to premature death to 
include equivalent years of healthy life lost by virtue of being in states of poor health or 
disability” (WHO, 2008)
8. “The sum of these DALYs across the population represents the 
burden of disease and can be thought of as a measurement of the gap between current health 
status and an ideal health situation where the entire population lives to an advanced age, free 
of  disease  and  disability”  (WHO,  http://www.who.int/healthinfo/global_burden 
disease/metrics_daly/en/). DALYs were calculated initially for about one hundred causes and 
diseases and over the whole word (World Bank, 1993) and were not updated since 1999. 
From1999 to 2004 however, DALYs are also available on a regional basis. DALY figures are 
commonly used in cost-effectiveness analyses but, to the best of our knowledge, have never 
been used in macroeconomic analyses since DALYs by country are only available for 2002 
and 2004. 
Any indicator, including DALYs, is amenable to criticism with a particular emphasis on 
weighting (namely age and disease severity) and discounting (e.g. Anand and Hanson, 1997). 
A large revision has been however implemented, mainly by the Institute of Health Metrics, 
which is in charge DALYs calculations updates and improvements (Lopez et al, 2006). This 
does  not  prevent  however  this  indicator  from  being  a  serious  candidate  for  representing 
population  global  health  status,  deriving  from  illness  consequences  which  are  taken  into 
consideration in a single indicator. 
DALYs  are  either  available  for  each  WHO  14  regions  from  1999  to  2002  and  2004 
(regional DALY) or for each WHO country (country DALY) only in 2002. Weighting the 
WHO regional data by the ratio of the country 2002 DALY to regional 2002 DALY allows 
generating DALY at the country level:
9. 
                                                 
8 The DALYs for each health condition are the sum of the years of life lost (YLL) due to premature mortality 
and the years lost due to disability (YLD) for incident cases of the health condition. YLL are calculated from the 
number of deaths at each age multiplied by a global standard life expectancy for each age. YLD is the number of 
incident cases in a particular period × average duration of the disease × weight factor. The weight factor reflects 
the severity of the disease on a scale from 0 (perfect health) to 1 (death). See WHO (2008). 
9 Corrected country DALY in t = regional DALY in t * ( 1 + (country 2002 DALY-regional 2002 DALY)/ regional 2002 









































Corrected Country DALY in t = regional DALY in t * (2002 country DALY / 2002 regional 
DALY). 
with t = 1999, 2000, 2001, 2002, 2004 
This correction which increases the number of periods is valid under the hypothesis that the 
gap between the DALY per capita of a country and the DALY per capita of the WHO region 
in  which  it  belongs  is  constant  on  the  1999-2004’  period.  Such  assumption  seems  rather 
strong but can be justified when one considers that a country’s health conditions can hardly 
evolve over a short period 
The  relation  between  health  and  growth  is  estimated  either  using  Corrected  Country 
DALYs  (CCD)  or  regional  DALYs.  DALYs  calculated  with  respect  to  communicable 
diseases are also considered since communicable diseases, and more specifically, malaria, 
constitute a large part of the disease burden in low and middle income countries. 
We consider several control variables k X , which are either assumed from the theoretical 
model or inferred from other cross-country analyses of Solow augmented growth regressions. 
Initial GDP per capita allows considering conditional convergence when it exhibits a negative 
effect on growth; annual growth rates of population and investment ratio to GDP have resp. a 
negative and positive effect on growth (e.g. Mankiw et al. 1992). In addition to the global 
health indicator, other human capital variables are included. Lagged female school enrollment 
rates are preferred to male school enrollment as it may also reflect the inequality level that has 
an impact on growth. Lagged variables may cope with endogeneity bias. 
A second group of control variables includes the Government consumption ratio to GDP, 
openness and inflation rates. The government consumption does not have a clear-cut effect on 
growth (Barro, 1990). Openness and inflation allows taking economic policy variables with 
resp. a positive and a negative effect on growth. A variable taken from ICRG allows including 
institutional quality which positively affects growth.  
The characteristics of each variable are reported in Table A1, Appendix A. This table is 
completed by Table A2 in Appendix A which presents the correlations between important 









































4.2.  Econometric specification 
OLS estimation of equation (1) is potentially biased. First there can be a simultaneity bias 
between global health status and growth (e.g. Bonnel 2000; Bloom, Canning and Malaney 
2000; Sachs et al. 1999, 2003; Strauss and Thomas, 2008; Schultz, 2008). Measurement errors 
of the global health indicator may also induce biased estimators. To deal with these problems, 
we draw on instrumental variables techniques and therefore identify two instruments.  
The first is malaria ecology developed by Kiszewski and Sachs et al. (2004) and first used 
for cross-country regressions by Sachs (2003) and Carstensen and Gundlach (2006). Malaria 
ecology is built upon climatic factors and specific biological properties of each regionally 
dominant malaria vector which only reflects the forces of biological evolution and is thus 
independent  from  present  health  interventions  and  economic  conditions.  Moreover  germs 
likely to be affected by economic conditions or public health interventions (like mosquito 
abundance, for example) do not enter the calculation of the index (Kiszewski and Sachs et al. 
2004; Carstensen and Gundlach 2006).  
The other instrument used in this paper is the proportion of each country’s population 
threatened by a risk of malaria transmission in 1994. This indicator affects current economic 
growth only through health status and is unlikely affected by current economic conditions.  
5.  Econometric results 
Equation (1) is estimated with the heteroskedastic-efficient two-step generalized method of 
moments (IV-GMM) estimator which generates efficient coefficients as well as consistent 
standard errors estimates. (Hayashi 2000 pp.206-13 and 226-27; Baum et al. 2007). 
5.1.  Main results 
Results of GMM estimations are presented in Table 1 below. The first column reports 
estimates with corrected DALYs. Our instruments are either validated by the Shea R² and 
Hansen  over-identification  test  or  the  first  stage  estimation  results  presented  Table  A4 
(Appendix  A).  Contrary  to  OLS  estimates,
10  Health  is  found  to  have  a  negative  and 
statistically significant effect on economic growth thus validating the attenuation bias. This 
result is robust to variants of DALYs (columns 2 to 4). The effect of communicable diseases 
DALYs (col. 4) may reflect the importance of communicable diseases in health status in the 
                                                 









































world  that  are  yet  now  the  main  causes  of  DALYs  losses  in  developing  and  transitional 
countries. By contrast, the coefficient of DALYs for malaria is lower (-0,011), indicating that 
malaria is just one among other health main causes. 
Table 1. Two-step GMM estimation of economic effects of DALYs per capita 
 
  Dependent variable: GDP per capita growth 
Variables  (1)  (2)  (3)  (4)  (5) 
           
Log Corrected DALYs  -0.036
***         
  (3.51)         
Log Regional DALYs    -0.056
**       
    (2.54)       
Log DALYs in 2002      -0.036
***     
      (3.48)     
Log Communicable DALYs        -0.040
**   
        (2.12)   
Log Malaria DALYs          -0.011
** 
          (2.57) 






  (5.05)  (4.11)  (5.02)  (3.09)  (4.07) 






  (2.45)  (3.07)  (2.45)  (2.83)  (3.60) 
Population growth rate  0.327  0.171  0.314  0.266  0.558
* 
  (0.98)  (0.49)  (0.93)  (0.62)  (1.68) 
Government consumption  -0.003  -0.042  -0.003  -0.100  -0.057 
  (0.07)  (0.85)  (0.08)  (1.39)  (1.13) 
Openness  0.003  0.005  0.004  0.002  0.001 
  (1.27)  (1.43)  (1.35)  (0.55)  (0.15) 
Inflation rate  -0.024




  (1.72)  (1.54)  (1.71)  (1.67)  (2.51) 
Female School enrollment lag  -0.013  -0.002  -0.013  0.008  0.003 
  (1.26)  (0.19)  (1.29)  (0.55)  (0.26) 
Institutions  0.110  0.103  0.104  0.143  0.135 







  (3.84)  (2.77)  (3.82)  (2.38)  (2.73) 
Regional dummies  Yes  yes  yes  yes  yes 
Observations  124  124  124  124  124 
R²  0.301  0.130  0.296  -0.242  0.202 
Shea partial R²  0.365  0.163  0.364  0.080  0.145 
Hansen OID p-value  0.325  0.314  0.297  0.481  0.433 
Note: Health variables are instrumented by Malaria Ecology and Malaria Risk.  
***significant at 1%, **significant at 5%, *significant at 10%. Robust t-statistics enter parenthesis.  










































These results are in conformity with some important previous works (Bloom et al. 2004). 
They stress that a global health indicator is an important predictor of economic development 
on  a  large  sample  of  poor  and  rich  countries.  They  also  underline  the  importance  of  the 
identification strategy in the assessment of the economic effect of health status.  
One  could  argue  that  explanatory  variables  such  as  investment  rate  and  Government 
expenditure are also endogenous. The endogeneity of these variables comes from the reverse 
causality since rich countries are able to invest and spend in consumption. To solve for this, 
we instrument these variables with their value in previous period. The results obtained are 
summarized  in  Table  2  and  the  first  stage  estimation  results  are  presented  in  Table  A6 
Appendix A. 
The  effect  of  health  indicators  remains  negative  and  statistically  significant  with  very 









































Table 2. Two-step GMM estimation of economic effects of DALYs per capita, instrumenting 
Government expenditure 
  Dependent variable: GDP per capita growth gdpgrowth 
gdpgrowth  Variables  (1)  (2)  (3)  (4)  (5) 
           
Log Corrected DALYs  -0.038
***         
  (3.71)         
Log Regional DALYs    -0.056
***       
    (2.64)       
Log DALYs in 2002      -0.038
***     
      (3.67)     
Log Communicable DALYs        -0.038
**   
        (2.32)   
Log Malaria DALYs          -0.011
*** 
          (2.79) 






  (5.26)  (4.22)  (5.21)  (3.42)  (4.49) 
Investment ratio to GDP  0.058  0.100  0.059  0.149
*  0.156
** 
  (0.75)  (1.38)  (0.77)  (1.76)  (2.13) 
Population growth rate  0.291  0.174  0.275  0.323  0.569
* 
  (0.86)  (0.49)  (0.81)  (0.77)  (1.74) 
Government consumption  0.018  0.009  0.018  -0.044  -0.036 
  (0.41)  (0.16)  (0.42)  (0.63)  (0.66) 
Openness  0.004  0.006  0.004  0.002  0.001 
  (1.36)  (1.53)  (1.43)  (0.52)  (0.13) 
Inflation rate  -0.025  -0.026  -0.025  -0.025  -0.030
** 
  (1.53)  (1.51)  (1.52)  (1.53)  (2.10) 
Female school enrollment lag  -0.010  -0.001  -0.010  0.006  0.003 
  (0.98)  (0.12)  (1.02)  (0.43)  (0.23) 
Institution  0.148  0.113  0.142  0.138  0.154 







  (3.95)  (2.92)  (3.92)  (2.64)  (2.72) 
Observations  123  123  123  123  123 
R²  0.279  0.126  0.275  -0.192  0.200 
Shea partial R² of health variable  0.371  0.177  0.371  0.099  0.168 
Shea partial R² of investment  0.440  0.453  0.440  0.452  0.447 
Shea partial R² of Gov. Cons.  0.750  0.758  0.749  0.691  0.688 
Hansen OID p-value  0.233  0.215  0.211  0.410  0.409 
Note: Health variables are instrumented by Malaria Ecology and Malaria Risk. Investment ratio and Government 
Consumption are instrumented by their lag. 
***significant at 1%, **significant at 5%, *significant at 10%. Robust t-statistics enter parenthesis.  











































5.2.  Robustness analyses 
Our previous results relying on the IV technique may still be questioned. First, they may be 
due to the large health outcome gap between developed and developing countries, and may 
not  satisfactorily  explain  development  levels  gaps  between  developing  or  developed 
countries.  Secondly,  it  is  relevant  to  investigate  the  role  of  health  in  the  explanation  of 
development differential within countries which share a common characteristic related to poor 
basic health infrastructures. Equation (1) is therefore estimated on a low and middle-income 
countries sub-sample of which results are presented in Table 3 and the first stage estimation 
results are presented in Table A6 Appendix A. They are similar to those obtained for the 
whole sample, namely, health remains an important determinant of economic growth, even 
coefficients are smaller than those previously obtained (0,021 against 0,0036 for Corrected 









































Table 3: Two-step GMM estimation of economic effects of DALYs per capita, developing 
countries 
  Dependent variable: GDP per capita growth 
Variables  (1)  (2)  (3)  (4)  (5) 
Log Corrected DALYs  -0.021
**         
  (2.08)         
Log Regional DALYs    -0.031
*       
    (1.86)       
Log DALYs in 2002      -0.020
**     
      (2.07)     
Log Communicable DALYs        -0.018
*   
        (1.91)   
Log Malaria DALYs          -0.006
* 
          (1.72) 






  (3.43)  (3.41)  (3.42)  (3.31)  (3.38) 






  (2.51)  (2.93)  (2.50)  (3.38)  (3.71) 
Population growth rate  0.243  0.251  0.235  0.355  0.414 
  (0.60)  (0.61)  (0.58)  (0.87)  (1.02) 
Government consumption  0.060  0.038  0.060  0.018  0.018 
  (1.17)  (0.80)  (1.16)  (0.38)  (0.40) 
Openness  -0.009  -0.007  -0.009  -0.011
*  -0.009 
  (1.54)  (1.13)  (1.51)  (1.66)  (1.62) 






  (2.22)  (2.05)  (2.22)  (2.26)  (2.31) 
Female school enrollment lag  -0.007  -0.002  -0.007  -0.000  -0.004 
  (0.76)  (0.19)  (0.78)  (0.04)  (0.42) 
Institution  0.147  0.175  0.143  0.212  0.207 





**  0.054 
  (2.39)  (2.16)  (2.37)  (2.25)  (1.52) 
Observations  87  87  87  87  87 
R²  0.511  0.476  0.509  0.495  0.550 
Shea partial R²  0.425  0.236  0.428  0.205  0.243 
Hansen OID p-value  0.261  0.262  0.246  0.288  0.202 
Note: Health variables are instrumented by Malaria Ecology and Malaria Risk.  
***significant at 1%, **significant at 5%, *significant at 10%. Robust t-statistics enter parenthesis. 









































6.  Concluding remarks 
This  study  contributes  to  the  debate  on  the  relationship  between  health  outcomes  and 
economic performance by paying a particular attention to global health status measurement 
issues. We argue that, traditional health indicators such as life expectancy and mortality rates 
are inadequate to explain the overall health status in a population since they present many 
drawbacks and are devoted to a particular health problem. An accurate health indicator must 
measure the gap between current health status and an ideal health situation where the entire 
population  lives  to  an  advanced  age,  free  of  diseases  and  disabilities.  This  aspect  is 
specifically addressed by the disability-adjusted life year (DALY) proposed by the World 
Bank and WHO. Using this indicator in an augmented Solow growth model, the results show 
that global health outcomes as well as less aggregated health measurement (communicable 
diseases and malaria) remain important predictors of economic development. Our results are 
similar to those found in previous literature, even though they still contradict recent works 
such as Acemoglu and Robinson’s (2009).  
Our results support the idea improving health status is a prerequisite for development, and 
will contribute to play a role in poverty reduction (Dodd and Cassels, 2006; WHO, 2004). 
Health issues represent a challenge rather than a handicap. For example reducing malaria 
prevalence and other communicable diseases by paying more attention to water and sanitation 
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Table A1: Variables characteristics and source 
   mean  min  Max  coef. 
Var. 
sd  N     Source 
gdp. Growth  0,04  -0,05  0,10  0,62  0,02  159    WDI 2007 
log corrected Daly  5,42  4,59  6,86  0,11  0,58  159    WHO 
log Daly 2002  5,42  4,59  6,85  0,11  0,57  159    WHO 
log Comm. Disease  3,89  1,48  6,61  0,39  1,53  159    WHO 
log Malaria  -0,65  -8,87  4,30  -5,69  3,70  121    Sachs 2003 
Mal. Ecology  3,84  0,00  31,55  1,76  6,77  149    Sachs 2003 
Mal. Risk  0,31  0,00  1,00  1,34  0,42  145    Sachs 2003 
pop. Growth  1,42  -1,11  7,03  0,84  1,19  159    WDI 2007 
invest.  0,21  0,08  0,55  0,31  0,07  159    WDI 2007 
gov. Expend.  0,16  0,05  0,55  0,39  0,06  159    WDI 2007 
Openness  0,87  0,21  3,92  0,55  0,48  159    WDI 2007 
Inflation  0,08  -0,01  1,20  1,76  0,14  159    WDI 2007 
School  0,93  0,22  1,30  0,23  0,21  159    UNICEF 




Table A2: Correlation between the main variables 
   GDP growth 
Corrected 
Daly  Investment  Pop.growth 
Gov. 
Expend.  Openness  Inflation 
               
Corrected Daly  0.04  1           
fbcf  0.27***  -0.16**  1         
pop.growth  0.03  0.47***  -0.18**  1       
Gov. Expend.  -0.24***  -0.21***  0.12  -0.11  1     
openness  0.11  -0.23***  0.25***  -0.13*  0.19**  1   
inflation  -0.18**  0.24***  -0.16**  -0.02  -0.06  -0.08  1 










































Table A3: OLS estimation of the economic effects of health status 
  Dependent variable: GDP per capita growth 
Variables  (1)  (2)  (3)  (4)  (5) 
           
Log Corrected DALYs  -0.009         
  (1.39)         
Log Regional DALYs    -0.001       
    (0.15)       
Log DALYs in 2002      -0.008     
      (1.29)     
Log Communicable DALYs        0.001   
        (0.16)   
Log Malaria DALYs          -0.002 
          (1.34) 






  (3.42)  (2.74)  (3.35)  (2.46)  (3.56) 






  (3.25)  (3.55)  (3.26)  (3.57)  (3.61) 
Population growth rate  0.282  0.259  0.277  0.257  0.324 
  (1.24)  (1.14)  (1.22)  (1.12)  (1.40) 
Government consumption  -0.008  -0.013  -0.009  -0.012  -0.019 
  (0.21)  (0.33)  (0.22)  (0.29)  (0.47) 
Openness  0.004  0.004  0.004  0.004  0.003 
  (1.02)  (1.10)  (1.04)  (1.12)  (0.90) 






  (2.46)  (2.64)  (2.48)  (2.68)  (2.65) 
Female school enrollment lag  -0.005  -0.004  -0.005  -0.004  -0.003 
  (0.49)  (0.34)  (0.48)  (0.36)  (0.24) 
Institution  0.050  0.030  0.047  0.026  0.047 
  (0.36)  (0.21)  (0.34)  (0.19)  (0.34) 
Constant  0.103
*  0.045  0.099
*  0.033  0.046
* 
  (1.95)  (0.76)  (1.86)  (0.94)  (1.93) 
Regional dummy  yes  yes  yes  yes  yes 
Observations  126  126  126  126  126 
R²  0.394  0.384  0.393  0.384  0.393 
***significant at 1%, **significant at 5%, *significant at 10%.  Robust t-statistics enter parenthesis 
  Health  variable  is  represented  by  corrected  DALYs  (column  1),  WHO  regional  level  DALYs  (columns  2), 















































Table A4: first stage estimation results (whole sample) ++ 
  Dependent variables 

















Malaria Ecology  0.014
*  0.010
*  0.014
*  0.012  0.047 
  (1.83)  (1.75)  (1.94)  (1.22)  (1.54) 






  (3.77)  (2.04)  (3.71)  (1.89)  (2.17) 
N  124  124  124  124  124 
Note: ***significant at 1%; **significant at 5%; *significant at 10%.  t-statistics in parenthesis. 





Table A5: First stage estimation results (health, investment and Gover. Consump. variables instrumented) ++ 
  Dependent variables 





















Malaria Ecology  0.012
*  0.011
*  0.013
*  0.014  0.049  0.001  -0.001 
  (1.66)  (1.77)  (1.76)  (1.36)  (1.52)  (0.82)  (0.85) 





**  -0.016  0.010 
  (4.25)  (2.13)  (4.19)  (2.04)  (2.35)  (0.96)  (0.87) 
Investment lag  -0.018  0.223  -0.028  1.390  5.326
*  0.637
***  0.026 
  (0.04)  (0.48)  (0.06)  (1.31)  (1.82)  (7.93)  (0.53) 
Govern. 
Consump. lag  0.706  0.218  0.740  -0.836  -2.688  -0.011  0.831
*** 
  (1.41)  (0.42)  (1.48)  (0.70)  (0.90)  (0.15)  (15.55) 
N  123  123  123  123  123  123  123 
Note: ***significant at 1%; **significant at 5%; *significant at 10%.  t-statistics in parenthesis. 


















































Table A6: first stage estimation results (Developing countries) ++ 
  (1)  (2)  (3)  (4)  (5) 











Malaria_Ecology  0.009  0.008  0.010  0.012  0.056 
  (1.42)  (1.26)  (1.56)  (1.06)  (1.64) 






  (5.85)  (2.66)  (5.87)  (2.82)  (2.15) 
Observations  87  87  87  87  87 
Note: ***significant at 1%; **significant at 5%; *significant at 10%.  t-statistic in parenthesis. 
























































































Table A7: List of countries 
country list 
Albania    Ghana    Panama 
Algeria    Greece    Papua New Guinea 
Argentina    Grenada    Paraguay 
Armenia    Guatemala    Peru 
Australia    Guinea    Philippines 
Austria    Guinea-Bissau    Poland 
Azerbaijan    Guyana    Portugal 
Bahrain    Haiti    Romania 
Bangladesh    Honduras    Russian Federation 
Belarus    Hungary    Rwanda 
Belgium    Iceland    Saudi Arabia 
Belize    India    Senegal 
Benin    Indonesia    Seychelles 
Bhutan    Iran, Islamic Rep.    Sierra Leone 
Bolivia    Ireland    Singapore 
Bosnia and Herzegovina    Israel    Slovak Republic 
Botswana    Italy    Slovenia 
Brazil    Jamaica    Spain 
Bulgaria    Japan    Sri Lanka 
Burkina Faso    Jordan    St. Kitts and Nevis 
Burundi    Kazakhstan    St. Lucia 
Cambodia    Kenya    St. Vincent and the Grenadines 
Cameroon    Korea, Rep.    Sudan 
Canada    Kuwait    Suriname 
Cape Verde    Kyrgyz Republic    Swaziland 
Central African Republic    Latvia    Sweden 
Chad    Lebanon    Switzerland 
Chile    Lesotho    Syrian Arab Republic 
China    Liberia    Tajikistan 
Colombia    Lithuania    Tanzania 
Comoros    Luxembourg    Thailand 
Congo, Dem. Rep.    Macedonia, FYR    Togo 
Congo, Rep.    Madagascar    Tonga 
Costa Rica    Malawi    Trinidad and Tobago 
Cote d'Ivoire    Malaysia    Tunisia 
Croatia    Maldives    Turkey 
Cyprus    Mali    Uganda 
Czech Republic    Malta    Ukraine 
Denmark    Mauritania    United Arab Emirates 
Djibouti    Mauritius    United Kingdom 
Dominica    Mexico    United States 
Dominican Republic    Moldova    Uruguay 
Ecuador    Mongolia    Uzbekistan 
Egypt, Arab Rep.    Morocco    Vanuatu 
El Salvador    Mozambique    Venezuela, RB 
Eritrea    Namibia    Vietnam 
Estonia    Nepal    Yemen, Rep. 
Ethiopia    Netherlands    Zambia 
Fiji    New Zealand    Zimbabwe 
Finland    Nicaragua      
France    Niger      
Gabon    Nigeria      
Gambia, The    Norway      
Georgia    Oman      












































Table A8: Literature review on the effect of health on economic growth 
 





data  Estimator  Journal  Other covariates 
Barro and 















Male and female secondary 
schooling,  I/GDP,  G/GDP, 
log(1+black  market 
premium), revolutions 
Cuddington 
John T.  and 
Hancock 
John D.  


































Male and female secondary 
and  higher  education, 
log(GDP)  ·  human  capital, 
public  spending  on 




log(1+black  market 
premium),  political 
instability,  growth  rate  in 
terms of trade 











3SLS using lagged 






Male secondary and higher 
schooling, log(GDP) · male 
schooling, log fertility rate, 
government  consumption 
ratio,  rule  of  law  index, 
terms  of  trade  change, 
democracy  index,  demo- 
cracy  index  squared, 





















Male and female schooling, 
I/GDP,  G/GDP,  black 





(2.60)  Sachs and 
















Number 3, pp. 
335-376 
Openness,  openness 
xlog(GDP),  land-locked, 
government saving, tropical 
climate,  institutional 
quality,  natural  resource 
exports,  growth  in 
economically  active 















































data  Estimator  Journal  Other covariates 
Bloom and 














Log  secondary  schooling, 
openness,  institutional 
quality, central government 
deficit,  percentage  area  in 
tropics,  log  coastal 
population  density,  log 
inland  population  density, 
total  population  growth 
rate,  working-  age 
population  growth  rate, 
Africa dummy 
Bloom and 












Vol. 26, No. 11. 
pp. 2073-2085, 
1998 
Population  growth,  growth 
of  economically  active 
populations,  log  years  of 
secondary  schooling, 
natural resource abundance, 
openness,  institutional 
quality,  access  to  ports, 
average  government 
savings,  tropics,  ratio  of 
coastline  distance  to  land 
area 
Bloom and 














Population  growth  rate, 
working-  age  population 
growth  rate,  log  years  of 
secondary  schooling, 
natural resource abundance, 
openness,  institutional 
quality,  access  to  port, 
average  government 
savings  rate,  tropics 
dummy, ratio of coastline to 
land area 
life 
expectancy  2.4  (1.34) 
Gallup J. L., 












2SLS with malaria 
idex instrument by 
temperate 
(temperate, boreal, 
and polar ecozones), 










22, 2: 179–232 
Years  of  secondary 
schooling, openness, quality 
of  public  institutions, 
population  within  100 
kilometers  of  the  coast, 
malaria  index  in  1966, 
change  in  malaria  index 




(0.020)  Hamoudi 














OLS  CID Working 
Paper No. 30 
Institutional  quality, 
openness,  net  government 
savings,  tropics  land  area, 
log  coastal  population 
density,  population  growth 
rate,  working-age 


































































Log  of  ratio  of  total 
population  to  working-age 
population,  tropics,  log  of 
years  of  secondary 
schooling,  openness, 
institutional  quality, 
population  growth  rate, 
working  age  population 
growth rate 







OLS and 2SLS   World bank 
Log GDP 1990, Log phone 
per  capita,  Macro  rating, 
Law  rating,  Primary 
enrollment  rate,  Malaria 














2SLS using lagged 
values as intruments 
World 
Development 
Vol. 28, No. 2, 
pp. 197-219, 
2000 
change  in  the  log  of  life 
expectancy  1962-82,  gross 
domestic  investment, 



























Tropics,  openness,  log 
fertility,  log 
(Investment/GDP) 
Mayer David 2001 
Probability 
of survival 














Vol. 29, No. 6, 
pp. 1025–1033, 
2004 
Schooling,  investment, 





-2.5   (0.71)  Gallup J. L. 










2SLS with the 
prevalence of 53 
different Anopheles 
mosquito vectors in 
each country in 





Hygiene, 64 (1, 
2)S 85-96 
Years  of  secondary 
schooling, openness, quality 
of  public  institutions, 
population  within  100 
kilometers  of  the  coast, 
malaria  index  in  1966, 
change  in  malaria  index 
from 1966 to 1994 















The Journal of 
Economic 
History, Vol. 





























































data  Estimator  Journal  Other covariates 
Bloom David 












Nonlinear two stage 
least squares with 
lagged as instrument 
World 
Development 
Vol. 32, No. 1, 
pp. 1–13, 2004 
Capital,  labor,  Schooling, 
Experience,  Technological 
catch-up  coefficient, 
Percentage  of  land  area  in 
the tropics and Governance 
Health 
services,   
0,0021    
(0.006) 


















14, August 2005 














OLS  CDDRL 
working paper 
capital, labor, schooling, 
Environment, 
Technological catch-up 
coefficient, Percentage of 
land area in the tropics, 
Openness, Percentage oft 
land within 100 kilometers 






































interstate battle death 
Acemoglu 
Daron  and 
Johnson 
Simon  
2006  Life 

























Review, vol. 20, 
N°3 
Institutional  quality, 
climatic  factors  and 
geographic characteristic 
McDonald 
Scott  and 
Roberts 
Jennifer  





1998 for all 
countries. 






(2006) 228– 250 
Income  per  capita, 
investment,  population 
growth, schooling, proteins, 
malaria,  infant  mortality, 
life expectancy. 
Weil David 





















122, N°3, 1265- 
1306 
investment, education 
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